Psychiatry & Neurology, Clinical Neurophysiology · New York, NY
NPI
1467405399
Since 2006
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
301 E 17th St, Suite 1534
New York, NY, 10003
Phone (212) 598-6185
Groups this clinician bills Medicare through
Medicare paid, 2024
$161K
2,779 services
Medicare patients, 2024
711
Average age 74
Drug cost, 2024
$3.7M
1,444 prescriptions
Company payments, 2025
$217
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kiril Kiprovski was code 95886 (electrical nerve conductivity), 673 times for 360 patients. In total Kiril Kiprovski billed 2,779 services in 22 codes, and Medicare paid $161K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Office | 673 | 360 | $36.79 | $25K |
| 99214 Office E&M - Established | Office | 391 | 291 | $102.16 | $40K |
| 95911 Electrical Nerve Conductivity | Office | 214 | 212 | $107.36 | $23K |
| 95887 Electrical Nerve Conductivity | Office | 150 | 147 | $30.65 | $4,598 |
| 99204 Office E&M - New | Office | 89 | 89 | $141.95 | $13K |
| 36415 Venipuncture Blood Collection | Office | 84 | 81 | $8.65 | $727 |
| 95913 Electrical Nerve Conductivity | Office | 84 | 84 | $152.04 | $13K |
| 99205 Office E&M - New | Office | 60 | 60 | $181.67 | $11K |
| 95937 Electrical Nerve Conductivity | Office | 52 | 26 | $29.42 | $1,530 |
| 99215 Office E&M - Established | Office | 50 | 50 | $146.56 | $7,328 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 47 | 47 | $26.83 | $1,261 |
| 95872 Electrical Nerve Conductivity | Office | 45 | 23 | $113.85 | $5,123 |
| 95912 Electrical Nerve Conductivity | Office | 44 | 44 | $130.11 | $5,725 |
| 95910 Electrical Nerve Conductivity | Office | 44 | 44 | $83.68 | $3,682 |
| 99213 Office E&M - Established | Office | 14 | 14 | $68.70 | $962 |
By year: 2022 $165K for 3,202 services; 2023 $167K for 3,072 services; 2024 $161K for 2,779 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 84 | 81 | $8.65 | $727 |
Medicare prescription drug claims, 2024
In 2024, the drug Kiril Kiprovski prescribed most often to Medicare patients was Gabapentin, with 384 prescriptions and refills. In total Kiril Kiprovski wrote 1,444 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 384 | 469 | 91 | $3,705 |
| Pregabalin Generic | 149 | 169 | 33 | $2,782 |
| Duloxetine Hcl Generic | 114 | 159 | 27 | $1,581 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 84 | 142 | 23 | $1,325 |
| Nortriptyline Hcl Generic | 59 | 77 | 15 | $687 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 46 | 94 | 13 | $830 |
| Firdapse Amifampridine Phosphate | 43 | 43 | Under 11 | $2.1M |
| Riluzole Generic | 42 | 64 | 11 | $4,591 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 42 | 42 | Under 11 | $863K |
| Tizanidine Hcl Generic | 39 | 53 | 12 | $139 |
| Baclofen Generic | 26 | 30 | Under 11 | $225 |
| Aimovig Autoinjector Erenumab-Aooe | 24 | 24 | Under 11 | $17K |
| Pyridostigmine Bromide Generic | 22 | 52 | Under 11 | $1,896 |
| Primidone Generic | 18 | 24 | Under 11 | $160 |
| Meloxicam Generic | 17 | 23 | Under 11 | $49.92 |
Brand drugs: 176 claims; generic drugs: 1,268 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kiril Kiprovski $217 ($217 in general payments such as food, travel and fees) from 2 companies. The largest payer was Axsome Therapeutics, Inc. with $145.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.